Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02677220 · ClinicalTrials.gov registry record · NA
Implantation With the Nucleus CI532 Cochlear Implant in Adults
A NA study, sponsored by Cochlear.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02677220 is a NA study that was terminated before completion, run by Cochlear. The registered enrollment target is 1 participants.
The verdict
NCT02677220, a NA study, was terminated before completion, sponsored by Cochlear.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the clinical benefit for patients implanted with the Nucleus® CI532 cochlear implant. The Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the cochlea through a straightening sheath.
Interventions
- DEVICE CI532 cochlear implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-05-11 |
| Est. Completion | 2017-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02677220
The ClinicalTrials.gov registry entry for NCT02677220 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CI532 cochlear implant is the first listed.
NCT02677220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02677220 about?
NCT02677220 is a clinical study titled "Implantation With the Nucleus CI532 Cochlear Implant in Adults". The aim of this study is to investigate the clinical benefit for patients implanted with the Nucleus® CI532 cochlear implant. The Nucleus® CI532 has a pre-curved, perimodiolar array, the EA32, which is introduced into the cochlea through a straightening sheath.
What is the current status of trial NCT02677220?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-05-11. Estimated completion is 2017-08-23.
What interventions are being tested in trial NCT02677220?
The interventions under investigation include: CI532 cochlear implant (DEVICE).
Who is sponsoring clinical trial NCT02677220?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.